Linda l. kelley
Deparment of Immunology
Moffitt Cancer Center
United States of America
Dr. Linda L. Kelley is affiliated to Deparment of Immunology, Moffitt Cancer Center. Dr. Linda L. Kelley is currently providing services as Researcher. Dr. Linda L. Kelley has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Linda L. Kelley contributions have acclaimed recognition from honourable subject experts around the world. Dr. Linda L. Kelley is actively associated with different societies and academies. Dr. Linda L. Kelley academic career is decorated with several reputed awards and funding. Dr. Linda L. Kelley research interests include manufacture and compliance of approved cell therapies for stem cell transplantation of malignant and benign disease, as well as experimental therapies for immune modulation of cancer treatment.
Manufacture and compliance of approved cell therapies for stem cell transplantation of malignant and benign disease, as well as experimental therapies for immune modulation of cancer treatment
Wilson BD, Gibson CC, Sorensen LK, Guilhermier MY, Clinger M, Kelley LL, Shiu YT, Li DY. Novel approach for endothelializing vascular devices: understanding and exploiting elastin-endothelial interactions. Ann Biomed Eng. 2011 Jan;39(1):337-346.
Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One. 2012 Feb;6(10):e25968.
Mojica-Henshaw MP, Jacobson P, Morris J, Kelley L, Pierce J, Boyer M, Reems JA. Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy. 2013 Dec;15(12):1458-1468.